LEADER 01526nam  2200433z- 450 
001 9910694343203321
005 20070927085049.0
035   $a(CKB)5860000000031787
035   $a(BIP)016442809
035   $a(EXLCZ)995860000000031787
100   $a20220406c2007uuuu  -u-         -
101 0 $aeng
200 10$aProtections for foster children enrolled in clinical trials $ehearing before the Subcommittee on Human Resources of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005
215   $a1 online resource (iii, 71 p.) 
311   $a0-16-079306-8 
517   $aProtections for foster children enrolled in clinical trials 
606   $aClinical trials$zUnited States
606   $aFoster children$xMedical care$zUnited States
606   $aPatient advocacy$zUnited States
606   $aChild welfare$zUnited States
610   $aClinical trials
610   $aFoster children
610   $aChild health services
610   $aPatient advocacy
610   $aChild welfare
610   $aChildren
610   $aMedical
610   $aFamily & relationships
610   $aSocial science
610   $aHealth & fitness
610   $aPolitical science
615  0$aClinical trials
615  0$aFoster children$xMedical care
615  0$aPatient advocacy
615  0$aChild welfare
906   $aBOOK
912   $a9910694343203321
996   $aProtections for foster children enrolled in clinical trials$93133444
997   $aUNINA